ELMO2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.195700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.011500E-02
Normal-vs-Stage2
1.328220E-02
Normal-vs-Stage3
5.881700E-02
Normal-vs-Stage4
1.849560E-01
Stage1-vs-Stage2
7.870600E-01
Stage1-vs-Stage3
2.618200E-01
Stage1-vs-Stage4
6.630400E-01
Stage2-vs-Stage3
2.715600E-01
Stage2-vs-Stage4
5.072400E-01
Stage3-vs-Stage4
1.689780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.917600E-02
Normal-vs-AfricanAmerican
1.019210E-01
Normal-vs-Asian
3.809600E-02
Caucasian-vs-AfricanAmerican
8.202200E-01
Caucasian-vs-Asian
2.438400E-01
AfricanAmerican-vs-Asian
3.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.708500E-02
Normal-vs-Female
3.497500E-02
Male-vs-Female
9.891200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.322800E-01
Normal-vs-Age(41-60Yrs)
3.927700E-02
Normal-vs-Age(61-80Yrs)
5.680400E-02
Normal-vs-Age(81-100Yrs)
1.102170E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.834200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.799400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.724200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.508500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.602400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.741650E-03
Normal-vs-Daily Drinker
1.456260E-02
Normal-vs-Weekly Drinker
8.110200E-02
Normal-vs-Occasional Drinker
2.612200E-01
Normal-vs-Social Drinker
2.050000E-01
Non Drinker-vs-Daily Drinker
4.080200E-01
Non Drinker-vs-Weekly Drinker
1.012400E-01
Non Drinker-vs-Occasional Drinker
7.928000E-02
Non Drinker-vs-Social Drinker
1.161970E-02
Daily Drinker-vs-Weekly Drinker
4.016200E-01
Daily Drinker-vs-Occasional Drinker
2.274800E-01
Daily Drinker-vs-Social Drinker
9.721500E-02
Weekly Drinker-vs-Occasional Drinker
6.504400E-01
Weekly Drinker-vs-Social Drinker
4.683600E-01
Occasional Drinker-vs-Social Drinker
8.550200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.903000E-01
Normal-vs-Grade 2
8.769200E-01
Normal-vs-Grade 3
8.737400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.714200E-01
Grade 1-vs-Grade 3
4.112000E-01
Grade 1-vs-Grade 4
5.903000E-01
Grade 2-vs-Grade 3
9.383600E-01
Grade 2-vs-Grade 4
8.769200E-01
Grade 3-vs-Grade 4
8.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.088040E-02
Normal-vs-NonDiabetic
5.524000E-02
Diabetic-vs-NonDiabetic
4.408200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.433670E-02
Normal-vs-NoPancreatitis
5.021700E-02
Pancreatitis-vs-NoPancreatitis
6.970600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.437190E-01
Normal-vs-N1
1.739870E-02
N0-vs-N1
6.251200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.621800E-03
Normal-vs-TP53-NonMutant
2.217000E-01
TP53-Mutant-vs-TP53-NonMutant
4.633800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
